Login

IFIGENEIA Kickoff Meeting - Aristotle University of Thessaloniki, Greece, 3-4 April 2025

3–4 Apr 2025
Europe/Athens timezone

Contribution List

56 / 56
1. Registration
03/04/2025, 08:30
2. Welcome to IFIGENEIA
03/04/2025, 09:00
24. Greek Hub
03/04/2025, 09:15

AUTH - RCM - BIOKOSMOS - AMTH - CERTH - GNP - TPOLIS - NCSRD - YFOS
25. Slovenian Hub
03/04/2025, 10:00

UL - IJS - COSYLAB - SIH - IAS
26. Cypriot Hub
03/04/2025, 10:30

TALOS - UCY - PASYKAF - SHSO
27. Bosnian Hub
03/04/2025, 10:50

UNSA
28. Collaborators
03/04/2025, 11:00

CERN - DKFZ - GSI
29. Presentation from Project Officer + (Q&A)
Raquel FERNANDEZ HORCAJADA (EU)
03/04/2025, 11:45
30. Particle accelerators for societal applications
03/04/2025, 12:15

Alessandra Lombardi (TBC)
34. Invited talk on Radiopharmaceutical
03/04/2025, 12:45

Joao Seco (DKFZ)
45. T3.1 LINAC/RFQ design and beam dynamics studies
03/04/2025, 14:00

AUTH - CERN
46. T3.2 Beam parameters and hardware specifications for different operational scenarios
03/04/2025, 14:15

CERN
47. T3.3 Targets’ optimization and handling for different isotope production scenarios
03/04/2025, 14:30

AUTH - CERN
48. T3.4 Control system development project plan
03/04/2025, 14:45

COSYLAB
49. T3.5 Study of the Safety and Radiation protection requirements
03/04/2025, 15:00

NCSRD
50. T3.6 Development of Computational tools
03/04/2025, 15:15

AUTH
40. T4.1 Develop Lab conditions (radiation protection) needed for producing these isotopes.
03/04/2025, 15:50

BIOKOSMOS
41. T4.2 Identify best Isotopes for production with LINAC
03/04/2025, 16:05

UL
42. T4.3 Investigate best Ligands for development within excellent hub
03/04/2025, 16:20

UL - DKFZ
43. T4.4 Perform the development and testing of ligand-isotope compound
03/04/2025, 16:35

DKFZ
44. T4.5 Develop protocols for pre-clinical evaluation of ligand-isotope compound
03/04/2025, 16:50

GNP
51. T6.1 Accelerator School
03/04/2025, 17:40

UCY
52. T6.2 Master Classes in Particle Therapy
03/04/2025, 17:55

GSI
53. T6.3 Implementation of a Virtual Interactive RadioIsotope production unit
03/04/2025, 18:10

CERTH
54. T5.1 Management of Key Exploitable Results (KERs)
04/04/2025, 09:00

TALOS
55. T5.2 Development of Business Plan(s) for Seeking Financing beyond the Project
04/04/2025, 09:15

TALOS
56. T5.3 Basic Sustainability for the Excellence Hubs
04/04/2025, 09:30

RCM
15. T2.1 Communication and dissemination activities and planning
04/04/2025, 09:45

IJS
16. T2.2 Skills training and Trainers’ training
04/04/2025, 10:05

TPOLIS
17. T2.3 Secondments and good practices exchange
04/04/2025, 10:20

GNP
18. T2.4 Inclusion strategies and activities
04/04/2025, 10:35

AUTH
19. T1.1 Project coordination & financial management
04/04/2025, 11:10

AUTH
20. T1.2 Quality assurance, risks, ethics and IPR management
04/04/2025, 11:25

COSYLAB
21. T1.3 Scientific, innovation & technical management
04/04/2025, 11:40

AUTH
22. T1.4 Capacity Building
04/04/2025, 11:55

CY
23. T1.5 Data management
04/04/2025, 12:10

SHSO
38. Action points & Discussion
04/04/2025, 12:30

AUTH / All Partners
39. Next meeting arrangements and meeting closure
04/04/2025, 12:50

AUTH / All Partners
10. Bosnian Hub
9. Cypriot Hub
7. Greek Hub
3. Introduction per Institute
6. Introduction per Partner

All Partners
13. Lnch Break
14. Lunch Break
4. Presentation from the European Commission PO
Raquel FERNANDEZ HORCAJADA (EU)
8. Slovenian Hub
31. T5.1 Management of Key Exploitable Results (KERs)

TALOS
35. T5.1 Management of Key Exploitable Results (KERs)

TALOS
32. T5.2 Development of Business Plan(s) for Seeking Financing beyond the Project

TALOS
36. T5.2 Development of Business Plan(s) for Seeking Financing beyond the Project

TALOS
33. T5.3 Basic Sustainability for the Excellence Hubs

RCM
37. T5.3 Basic Sustainability for the Excellence Hubs

RCM
5. WP1: Project Management
11. WP3: LINAC design dedicated to radioisotope production and other societal applications

AUTH - CERN - COSYLAB - NCSRD
12. WP4: Radioisotope production and radiopharmaceuticals
Powered by Indico v3.3.4